12 Month Price Forecast For MASS
Distance to MASS Price Forecasts
MASS Price Momentum
🤔 Considering 908 Devices (MASS)?
Join 5,000+ investors getting our exclusive market analysis every Monday & Thursday. Stay ahead of breakout opportunities.
Disclaimer: The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Data last updated: January 23, 2025 10:03 AM UTC
MASS Analyst Ratings & Price Targets
Based on our analysis of 4 Wall Street analysts, MASS has a consensus that is bullish. The median price target is $6.00, with forecasts ranging from $4.00 to $6.00. Currently, there are 3 Buy ratings, 1 Hold ratings, and 0 Sell ratings.
With MASS currently trading at $2.81, the median price forecast suggests a 113.9% upside. The most optimistic forecast comes from Jacob Johnson at Stephens & Co., projecting a 113.9% upside, while Puneet Souda at Leerink Partners provides the most conservative target, suggesting a 42.6% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
MASS Analyst Consensus
MASS Price Target Range
Latest MASS Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for MASS.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Jan 15, 2025 | Stephens & Co. | Jacob Johnson | Overweight | Reiterates | $6.00 |
| Nov 13, 2024 | Stifel | Daniel Arias | Buy | Maintains | $6.00 |
| Nov 13, 2024 | Leerink Partners | Puneet Souda | Market Perform | Downgrade | $4.00 |
| Oct 17, 2024 | Leerink Partners | Outperform | Maintains | $12.00 | |
| May 13, 2024 | Stephens & Co. | Jacob Johnson | Overweight | Reiterates | $14.00 |
| Sep 25, 2023 | Stephens & Co. | Jacob Johnson | Overweight | Reiterates | $14.00 |
| Feb 7, 2023 | Stephens & Co. | Jacob Johnson | Overweight | Initiates | $14.00 |
| Jan 6, 2023 | SVB Leerink | Puneet Souda | Outperform | Maintains | $20.00 |
| Nov 15, 2022 | SVB Leerink | Puneet Souda | Outperform | Maintains | $25.00 |
| Mar 8, 2022 | SVB Leerink | Puneet Souda | Outperform | Maintains | $30.00 |
| May 14, 2021 | SVB Leerink | Puneet Souda | Outperform | Maintains | $65.00 |
| Jan 12, 2021 | Cowen & Co. | Outperform | Initiates | $0.00 | |
| Jan 12, 2021 | SVB Leerink | Outperform | Initiates | $0.00 | |
| Jan 12, 2021 | Stifel | Buy | Initiates | $0.00 |
Stocks Similar to 908 Devices Inc.
The following stocks are similar to 908 Devices based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
908 Devices Inc. (MASS) Financial Data
908 Devices Inc. has a market capitalization of $103.77M with a P/E ratio of -2.5x. The company generates $55.16M in trailing twelve-month revenue with a -109.1% profit margin.
Revenue growth is +17.3% quarter-over-quarter, while maintaining an operating margin of -70.6% and return on equity of -40.0%.
Valuation Metrics
Growth & Margins
Financial Health
🔥 Want More High-Potential Stock Ideas?
Join 5,000+ investors getting our research on stocks with massive upside potential.
908 Devices Inc. (MASS) Company Overview
About 908 Devices Inc.
Provides handheld and desktop mass spectrometry devices.
The company generates revenue by selling specialized mass spectrometry devices tailored for various industries, including life sciences, bioprocessing, and forensics. Their product lineup addresses the need for rapid analysis and real-time monitoring in complex processes, catering to markets that require precision and efficiency.
Incorporated in 2012 and headquartered in Boston, Massachusetts, 908 Devices operates globally, offering innovative solutions that enhance analytical capabilities in diverse applications. Their focus on developing purpose-built devices positions them strategically within the evolving landscape of scientific research and industrial processes.
Company Information
Sector
Healthcare
Industry
Medical Devices
Employees
230
CEO
Dr. Kevin J. Knopp Ph.D.
Country
United States
IPO Year
2020
Website
908devices.com908 Devices Inc. (MASS) Latest News & Analysis
908 Devices Inc. (Nasdaq: MASS) projected Q4 2024 revenue at approximately $17.2 million, a 20% increase from Q4 2023's $14.4 million, with growth in handheld revenues.
908 Devices Inc.'s projected 20% revenue growth signals strong demand for its products, potentially enhancing investor confidence and driving stock performance.
908 Devices Inc. (Nasdaq: MASS) partners with Getinge to integrate bioreactors with MAVEN for automated glucose and lactate monitoring in cell cultures, enhancing real-time analysis in bioprocessing.
The collaboration enhances bioprocessing efficiency, potentially increasing demand for 908 Devices' technology, which could lead to revenue growth and improved market positioning.
908 Devices Inc. (NASDAQ:MASS) will discuss its Q3 2024 earnings on November 12, 2024, at 8:30 AM ET. Key participants include CEO Kevin Knopp and CFO Joe Griffith.
Upcoming Q3 2024 earnings call for 908 Devices will reveal financial performance insights, impacting stock valuation and investor sentiment in a volatile market.
908 Devices Reports Third Quarter 2024 Financial Results and Updates 2024 Revenue Outlook
2 months ago908 Devices Inc. reported Q3 2024 financial results, noting year-over-year revenue growth from new products, but missed expectations due to federal budget delays and international contract issues.
908 Devices' revenue growth is overshadowed by unmet expectations and external challenges, signaling potential volatility and caution for investors regarding future performance.
908 Devices Inc. reported a quarterly loss of $0.23 per share, better than the Zacks Consensus Estimate of $0.29, compared to a loss of $0.22 per share a year prior.
908 Devices Inc. exceeded loss expectations, indicating potential operational improvement. A narrower loss than anticipated may boost investor confidence and positively impact stock performance.
908 Devices Inc. (Nasdaq: MASS) will participate in investor conferences on November 19 and 20, 2023, at the Stifel Healthcare Conference and Stephens Investment Conference, respectively.
908 Devices' participation in key investor conferences signals engagement with the investment community, potentially influencing stock interest and market perception of the company's growth prospects.
Frequently Asked Questions About MASS Stock
What is 908 Devices Inc.'s (MASS) stock forecast for 2025?
Based on our analysis of 4 Wall Street analysts, 908 Devices Inc. (MASS) has a median price target of $6.00. The highest price target is $6.00 and the lowest is $4.00.
Is MASS stock a good investment in 2025?
According to current analyst ratings, MASS has 3 Buy ratings, 1 Hold ratings, and 0 Sell ratings. The stock is currently trading at $2.81. Always conduct your own research and consider your investment goals before making investment decisions.
What is the price prediction for MASS stock?
Wall Street analysts predict MASS stock could reach $6.00 in the next 12 months. This represents a 113.9% increase from the current price of $2.81. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is 908 Devices Inc.'s business model?
The company generates revenue by selling specialized mass spectrometry devices tailored for various industries, including life sciences, bioprocessing, and forensics. Their product lineup addresses the need for rapid analysis and real-time monitoring in complex processes, catering to markets that require precision and efficiency.
What is the highest forecasted price for MASS 908 Devices Inc.?
The highest price target for MASS is $6.00 from Jacob Johnson at Stephens & Co., which represents a 113.9% increase from the current price of $2.81.
What is the lowest forecasted price for MASS 908 Devices Inc.?
The lowest price target for MASS is $4.00 from Puneet Souda at Leerink Partners, which represents a 42.6% increase from the current price of $2.81.
What is the overall MASS consensus from analysts for 908 Devices Inc.?
The overall analyst consensus for MASS is bullish. Out of 4 Wall Street analysts, 3 rate it as Buy, 1 as Hold, and 0 as Sell, with a median price target of $6.00.
How accurate are MASS stock price projections?
Stock price projections, including those for 908 Devices Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
